Selected research
Industry Research
Virtual Screening Technology Service Industry Research Report 2026
Market perspective
The global Virtual Screening Technology Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Virtual Screening Technology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Virtual Screening Technology Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Virtual Screening Technology Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Virtual Screening Technology Service include XtalPi, Insilico Medicine, Sygnature Discovery, Charles River, Pharmaron, Evotec, Cresset Group, BioSoIvelT and Enamine, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Virtual Screening Technology Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Virtual Screening Technology Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Virtual Screening Technology Service Market by Company
XtalPi
Insilico Medicine
Sygnature Discovery
Charles River
Pharmaron
Evotec
Cresset Group
BioSoIvelT
Enamine
Aurigene Services
Selvita
HITS
Standigm
Syntekabio
Pharmacelera
Receptor.AI
Chemspace
Jubilant Biosys
Aragen
Domainex
NUVISAN
Concept Life Sciences
Schrödinger
Cadence
WuXi AppTec
Virtual Screening Technology Service Segment by Type
Structure-Based Virtual Screening
Ligand-Based Virtual Screening
Others
Virtual Screening Technology Service Segment by Application
Pharmaceutical Industry
Biotechnology Industry
Academic Research Institutions
Others
Virtual Screening Technology Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virtual Screening Technology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Virtual Screening Technology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virtual Screening Technology Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Virtual Screening Technology Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Structure-Based Virtual Screening
- Ligand-Based Virtual Screening
- Others
Applications
- Pharmaceutical Industry
- Biotechnology Industry
- Academic Research Institutions
- Others
Companies covered
- XtalPi
- Insilico Medicine
- Sygnature Discovery
- Charles River
- Pharmaron
- Evotec
- Cresset Group
- BioSoIvelT
- Enamine
- Aurigene Services
- Selvita
- HITS
- Standigm
- Syntekabio
- Pharmacelera
- Receptor.AI
- Chemspace
- Jubilant Biosys
- Aragen
- Domainex
- NUVISAN
- Concept Life Sciences
- Schrödinger
- Cadence
- WuXi AppTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Virtual Screening Technology Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Structure-Based Virtual Screening
- 2.2.3 Ligand-Based Virtual Screening
- 2.2.4 Others
- 2.3 Virtual Screening Technology Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Biotechnology Industry
- 2.3.4 Academic Research Institutions
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Virtual Screening Technology Service Breakdown Data by Type
- 3.1 Global Virtual Screening Technology Service Historic Market Size by Type (2021-2026)
- 3.2 Global Virtual Screening Technology Service Forecasted Market Size by Type (2027-2032)
4 Virtual Screening Technology Service Breakdown Data by Application
- 4.1 Global Virtual Screening Technology Service Historic Market Size by Application (2021-2026)
- 4.2 Global Virtual Screening Technology Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Virtual Screening Technology Service Market Perspective (2021-2032)
- 5.2 Global Virtual Screening Technology Service Growth Trends by Region
- 5.2.1 Global Virtual Screening Technology Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Virtual Screening Technology Service Historic Market Size by Region (2021-2026)
- 5.2.3 Virtual Screening Technology Service Forecasted Market Size by Region (2027-2032)
- 5.3 Virtual Screening Technology Service Market Dynamics
- 5.3.1 Virtual Screening Technology Service Industry Trends
- 5.3.2 Virtual Screening Technology Service Market Drivers
- 5.3.3 Virtual Screening Technology Service Market Challenges
- 5.3.4 Virtual Screening Technology Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Virtual Screening Technology Service Players by Revenue
- 6.1.1 Global Top Virtual Screening Technology Service Players by Revenue (2021-2026)
- 6.1.2 Global Virtual Screening Technology Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Virtual Screening Technology Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Virtual Screening Technology Service Head Office and Area Served
- 6.4 Global Virtual Screening Technology Service Players, Product Type & Application
- 6.5 Global Virtual Screening Technology Service Manufacturers Established Date
- 6.6 Global Virtual Screening Technology Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Virtual Screening Technology Service Market Size (2021-2032)
- 7.2 North America Virtual Screening Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Virtual Screening Technology Service Market Size by Country (2021-2026)
- 7.4 North America Virtual Screening Technology Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Virtual Screening Technology Service Market Size (2021-2032)
- 8.2 Europe Virtual Screening Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Virtual Screening Technology Service Market Size by Country (2021-2026)
- 8.4 Europe Virtual Screening Technology Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Virtual Screening Technology Service Market Size (2021-2032)
- 9.2 Asia-Pacific Virtual Screening Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Virtual Screening Technology Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Virtual Screening Technology Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Virtual Screening Technology Service Market Size (2021-2032)
- 10.2 South America Virtual Screening Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Virtual Screening Technology Service Market Size by Country (2021-2026)
- 10.4 South America Virtual Screening Technology Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Virtual Screening Technology Service Market Size (2021-2032)
- 11.2 Middle East & Africa Virtual Screening Technology Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Virtual Screening Technology Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Virtual Screening Technology Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 XtalPi
- 12.1.1 XtalPi Company Information
- 12.1.2 XtalPi Business Overview
- 12.1.3 XtalPi Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.1.4 XtalPi Virtual Screening Technology Service Product Portfolio
- 12.1.5 XtalPi Recent Developments
- 12.2 Insilico Medicine
- 12.2.1 Insilico Medicine Company Information
- 12.2.2 Insilico Medicine Business Overview
- 12.2.3 Insilico Medicine Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.2.4 Insilico Medicine Virtual Screening Technology Service Product Portfolio
- 12.2.5 Insilico Medicine Recent Developments
- 12.3 Sygnature Discovery
- 12.3.1 Sygnature Discovery Company Information
- 12.3.2 Sygnature Discovery Business Overview
- 12.3.3 Sygnature Discovery Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.3.4 Sygnature Discovery Virtual Screening Technology Service Product Portfolio
- 12.3.5 Sygnature Discovery Recent Developments
- 12.4 Charles River
- 12.4.1 Charles River Company Information
- 12.4.2 Charles River Business Overview
- 12.4.3 Charles River Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.4.4 Charles River Virtual Screening Technology Service Product Portfolio
- 12.4.5 Charles River Recent Developments
- 12.5 Pharmaron
- 12.5.1 Pharmaron Company Information
- 12.5.2 Pharmaron Business Overview
- 12.5.3 Pharmaron Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.5.4 Pharmaron Virtual Screening Technology Service Product Portfolio
- 12.5.5 Pharmaron Recent Developments
- 12.6 Evotec
- 12.6.1 Evotec Company Information
- 12.6.2 Evotec Business Overview
- 12.6.3 Evotec Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.6.4 Evotec Virtual Screening Technology Service Product Portfolio
- 12.6.5 Evotec Recent Developments
- 12.7 Cresset Group
- 12.7.1 Cresset Group Company Information
- 12.7.2 Cresset Group Business Overview
- 12.7.3 Cresset Group Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.7.4 Cresset Group Virtual Screening Technology Service Product Portfolio
- 12.7.5 Cresset Group Recent Developments
- 12.8 BioSoIvelT
- 12.8.1 BioSoIvelT Company Information
- 12.8.2 BioSoIvelT Business Overview
- 12.8.3 BioSoIvelT Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.8.4 BioSoIvelT Virtual Screening Technology Service Product Portfolio
- 12.8.5 BioSoIvelT Recent Developments
- 12.9 Enamine
- 12.9.1 Enamine Company Information
- 12.9.2 Enamine Business Overview
- 12.9.3 Enamine Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.9.4 Enamine Virtual Screening Technology Service Product Portfolio
- 12.9.5 Enamine Recent Developments
- 12.10 Aurigene Services
- 12.10.1 Aurigene Services Company Information
- 12.10.2 Aurigene Services Business Overview
- 12.10.3 Aurigene Services Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.10.4 Aurigene Services Virtual Screening Technology Service Product Portfolio
- 12.10.5 Aurigene Services Recent Developments
- 12.11 Selvita
- 12.11.1 Selvita Company Information
- 12.11.2 Selvita Business Overview
- 12.11.3 Selvita Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.11.4 Selvita Virtual Screening Technology Service Product Portfolio
- 12.11.5 Selvita Recent Developments
- 12.12 HITS
- 12.12.1 HITS Company Information
- 12.12.2 HITS Business Overview
- 12.12.3 HITS Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.12.4 HITS Virtual Screening Technology Service Product Portfolio
- 12.12.5 HITS Recent Developments
- 12.13 Standigm
- 12.13.1 Standigm Company Information
- 12.13.2 Standigm Business Overview
- 12.13.3 Standigm Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.13.4 Standigm Virtual Screening Technology Service Product Portfolio
- 12.13.5 Standigm Recent Developments
- 12.14 Syntekabio
- 12.14.1 Syntekabio Company Information
- 12.14.2 Syntekabio Business Overview
- 12.14.3 Syntekabio Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.14.4 Syntekabio Virtual Screening Technology Service Product Portfolio
- 12.14.5 Syntekabio Recent Developments
- 12.15 Pharmacelera
- 12.15.1 Pharmacelera Company Information
- 12.15.2 Pharmacelera Business Overview
- 12.15.3 Pharmacelera Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.15.4 Pharmacelera Virtual Screening Technology Service Product Portfolio
- 12.15.5 Pharmacelera Recent Developments
- 12.16 Receptor.AI
- 12.16.1 Receptor.AI Company Information
- 12.16.2 Receptor.AI Business Overview
- 12.16.3 Receptor.AI Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.16.4 Receptor.AI Virtual Screening Technology Service Product Portfolio
- 12.16.5 Receptor.AI Recent Developments
- 12.17 Chemspace
- 12.17.1 Chemspace Company Information
- 12.17.2 Chemspace Business Overview
- 12.17.3 Chemspace Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.17.4 Chemspace Virtual Screening Technology Service Product Portfolio
- 12.17.5 Chemspace Recent Developments
- 12.18 Jubilant Biosys
- 12.18.1 Jubilant Biosys Company Information
- 12.18.2 Jubilant Biosys Business Overview
- 12.18.3 Jubilant Biosys Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.18.4 Jubilant Biosys Virtual Screening Technology Service Product Portfolio
- 12.18.5 Jubilant Biosys Recent Developments
- 12.19 Aragen
- 12.19.1 Aragen Company Information
- 12.19.2 Aragen Business Overview
- 12.19.3 Aragen Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.19.4 Aragen Virtual Screening Technology Service Product Portfolio
- 12.19.5 Aragen Recent Developments
- 12.20 Domainex
- 12.20.1 Domainex Company Information
- 12.20.2 Domainex Business Overview
- 12.20.3 Domainex Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.20.4 Domainex Virtual Screening Technology Service Product Portfolio
- 12.20.5 Domainex Recent Developments
- 12.21 NUVISAN
- 12.21.1 NUVISAN Company Information
- 12.21.2 NUVISAN Business Overview
- 12.21.3 NUVISAN Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.21.4 NUVISAN Virtual Screening Technology Service Product Portfolio
- 12.21.5 NUVISAN Recent Developments
- 12.22 Concept Life Sciences
- 12.22.1 Concept Life Sciences Company Information
- 12.22.2 Concept Life Sciences Business Overview
- 12.22.3 Concept Life Sciences Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.22.4 Concept Life Sciences Virtual Screening Technology Service Product Portfolio
- 12.22.5 Concept Life Sciences Recent Developments
- 12.23 Schrödinger
- 12.23.1 Schrödinger Company Information
- 12.23.2 Schrödinger Business Overview
- 12.23.3 Schrödinger Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.23.4 Schrödinger Virtual Screening Technology Service Product Portfolio
- 12.23.5 Schrödinger Recent Developments
- 12.24 Cadence
- 12.24.1 Cadence Company Information
- 12.24.2 Cadence Business Overview
- 12.24.3 Cadence Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.24.4 Cadence Virtual Screening Technology Service Product Portfolio
- 12.24.5 Cadence Recent Developments
- 12.25 WuXi AppTec
- 12.25.1 WuXi AppTec Company Information
- 12.25.2 WuXi AppTec Business Overview
- 12.25.3 WuXi AppTec Revenue in Virtual Screening Technology Service Business (2021-2026)
- 12.25.4 WuXi AppTec Virtual Screening Technology Service Product Portfolio
- 12.25.5 WuXi AppTec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst